4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-21-018632
EVP, GM Gene Therapy acquired 31,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Buck Jill EVP, GM Gene Therapy | 2021-03-04 | Grant or award | +31,500 | 231,016 | D | ||
| Derivatives | |||||||
| Buck Jill EVP, GM Gene Therapy | 2021-03-04 | Grant or award · Employee Stock Option (right to buy) | +236,250 | 236,250 | D | ||
Loading xslF345X03/doc4.xml…